XML 33 R24.htm IDEA: XBRL DOCUMENT
v3.23.1

Stock Options and Warrants (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract] |
Stock options outstanding |
Stock options outstanding |  |  |  |  |  |
|  | Options |  |  | Weighted Avg. Exercise Price |
Options outstanding, December 31, 2020 |  |  | 32,480,601 |  |  | $ | 0.18 |
Options granted |  |  | 800,000 |  |  |  | 0.03 |
Options exercised |  |  | – |  |  |  | – |
Options cancelled |  |  | (2,200,000 | ) |  |  | 0.30 |
Options outstanding, December 31, 2021 |  |  | 31,080,601 |  |  | $ | 0.17 |
Options granted |  |  | – |  |  |  | – |
Options exercised |  |  | (250,000 | ) |  |  | 0.08 |
Options cancelled |  |  | (4,773,000 | ) |  |  | 0.26 |
Options outstanding, December 31, 2022 |  |  | 26,057,601 |  |  | $ | 0.15 |
Schedule of options outstanding by per share price |
Schedule of options outstanding by per share price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Outstanding Options |  |  | Exercisable Options |
Option Exercise Price Per Share |  | Shares |  |  | Life (Years) |  |  | Weighted Average Exercise Price |  |  | Shares |  |  | Weighted Average Exercise Price |
$0.02 - $0.24 |  |  | 22,055,551 |  |  |  | 5.1 |  |  | $ | 0.10 |  |  |  | 22,055,551 |  |  | $ | 0.10 |
$0.25 - $0.49 |  |  | 3,388,552 |  |  |  | 3.6 |  |  |  | 0.36 |  |  |  | 3,388,552 |  |  |  | 0.36 |
$0.50 - $0.99 |  |  | 463,052 |  |  |  | 1.4 |  |  |  | 0.85 |  |  |  | 463,052 |  |  |  | 0.85 |
$1.00 - $2.00 |  |  | 150,446 |  |  |  | 0.6 |  |  |  | 1.18 |  |  |  | 150,446 |  |  |  | 1.18 |
|  |  | 26,057,601 |  |  |  | 4.8 |  |  | $ | 0.15 |  |  |  | 26,057,601 |  |  | $ | 0.15 |
Assumptions used for option valuation |
Assumptions used for option valuation |  |  |  |  |  |
|  | Years Ended |
|  | 2022 |  |  | 2021 |
Expected life (years) |  |  | – |  |  |  | 4.9 |
Risk free interest rate |  |  | – |  |  |  | 1.3% |
Volatility |  |  | – |  |  |  | 148% |
Expected dividend yield |  |  | – |  |  |  | 0% |
Schedule of warrant activity |
Schedule of warrant activity |  |  |  |  |  |
|  | Warrants |  |  | Weighted Avg. Exercise Price |
Warrants outstanding, December 31, 2020 |  |  | 8,683,677 |  |  | $ | 0.11 |
Warrants granted |  |  | 19,307,153 |  |  |  | 0.04 |
Warrants exercised |  |  | – |  |  |  | – |
Warrants cancelled |  |  | (8,013,681 | ) |  |  | 0.10 |
Warrants outstanding, December 31, 2021 |  |  | 19,977,149 |  |  | $ | 0.04 |
Warrants granted |  |  | 16,426,657 |  |  |  | 0.04 |
Warrants exercised |  |  | (14,483,825 | ) |  |  | 0.04 |
Warrants cancelled |  |  | (1,605,828 | ) |  |  | 0.04 |
Warrants outstanding, December 31, 2022 |  |  | 20,314,153 |  |  | $ | 0.04 |
Schedule of warrants outstanding by per share price |
Schedule of warrants outstanding by per share price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Outstanding Warrants |  |  | Exercisable Warrants |
Option Exercise Price Per Share |  | Shares |  |  | Life (Years) |  |  | Weighted Average Exercise Price |  |  | Shares |  |  | Weighted Average Exercise Price |
$0.02 - $0.24 |  |  | 20,244,153 |  |  |  | 1.0 |  |  | $ | 0.04 |  |  |  | 20,210,820 |  |  | $ | 0.04 |
$0.25 - $0.49 |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
$0.50 - $1.00 |  |  | 70,000 |  |  |  | 1.3 |  |  |  | 0.80 |  |  |  | 70,000 |  |  |  | 0.80 |
$1.00 - $2.00 |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |  |  |  | – |
|  |  | 20,314,153 |  |  |  | 1.0 |  |  | $ | 0.04 |  |  |  | 20,280,820 |  |  | $ | 0.04 |
Year Ending December 31, 2022
| · | In September 2022, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 14,409,995 shares of common stock with an exercise price of $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant. See Note 5 for further discussion.
| · | In January through December 2022, pursuant to terms of consulting agreements, the Company granted warrants to purchase 2,016,662 shares of common stock with an exercise price of $0.02 to $0.09 per share, vesting up to one month from the date of grant and expiring two to five years from the date of grant. Total fair value of these options at grant date was approximately $127,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 2 to 5 years; risk free interest rate of 0.13% to 4.49%; volatility of 193% to 245%; and dividend yield of 0%. During the year ended December 31, 2021, the Company recognized compensation expense of $127,000 based on the fair value of the warrants that vested.
Year Ending December 31, 2021
| · | In February through December 2021, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 18,907,157 shares of common stock with an exercise price of $0.03 to $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant. See Note 5 for further discussion.
| · | In January through December 2021, pursuant to terms of a consulting agreement, the Company granted warrants to purchase 399,996 shares of common stock with an exercise price of $0.02 to $0.05 per share, vesting one month from the date of grant and expiring two years from the date of grant. Total fair value of these options at grant date was approximately $13,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 2 years; risk free interest rate of 0.11% to 0.7%; volatility of 204% to 242%; and dividend yield of 0%. During the year ended December 31, 2021, the Company recognized compensation expense of $13,000 based on the fair value of the warrants that vested.

X
- References No definition available. + Details
Name: | qsep_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansByExercisePriceRangeTextBlock
Namespace Prefix: | qsep_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration